Can routinely collected administrative data effectively be used to evaluate and validate endpoints used in breast cancer clinical trials? Protocol for a scoping review of the literature

Can routinely collected administrative data effectively be used to evaluate and validate endpoints used in breast cancer clinical trials? Protocol for a scoping review of the literature

Abstract Background Randomized controlled trials (RCTs) are a critical component of evidence-based medicine and the evolution of patient care. However, the costs of conducting a RCT can be prohibitive. A promising approach toward reduction of costs and lessening of the burden of intensive and length...

Description complète

Détails bibliographiques
Auteurs principaux: Hely Shah, Dianna Wolfe, Mark Clemons, Michelle Liu, Kednapa Thavorn, Areti-Angeliki Veroniki, Carole Lunny, Greg Pond, Sharon McGee, Becky Skidmore, Angel Arnaout, Brian Hutton
Format: Article
Langue:English
Publié: BMC 2023-07-01
Collection:Systematic Reviews
Sujets:
Breast cancer
Recurrence
Administrative data
Real-world data
Scoping review
Accès en ligne:https://doi.org/10.1186/s13643-023-02283-5

Internet

https://doi.org/10.1186/s13643-023-02283-5

Documents similaires